Kraig Labs R&D Team continues to deliver outstanding breakthroughs
ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading
developer of spider silk based fibers, announces today that, in
recognition of the magnitude of multiple recent achievements, Dr. Trevor
Kane has been promoted to the position of Chief Scientist.
His successes in creating new transgenics in the lab, and expanding our
intellectual property portfolio with several new provisional patent
applications, mark a significant milestone and advancement in Kraig Labs
mission to produce and commercialize eco-friendly materials that exceed
the performance and strength of native spider silk.
“These new powerful transgenics, recently created by Dr. Kane’s team,
were designed for broad commercial appeal. Dr. Kane has certainly earned
his promotion with the successful development of this new architecture.
This next generation technology, developed in our labs, has the
potential to radically advance gains in material performance, above and
beyond anything we’ve previously produced,” said CEO and Founder, Kim
Thompson.
“I would like congratulate and commend Dr. Kane and our entire R&D team
for their success in developing these breakthrough technologies,” said
COO Jon Rice.
These new transgenics incorporate several technologies covered by the
Company’s recent provisional patent applications and set the stage for
new commercial applications.
To view the most recent news from Kraig Labs and/or to sign up for
Company alerts, please go to www.KraigLabs.com/news.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com),
a reporting biotechnology company, is the leading developer of
genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global textile
industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and
expectations other than historical facts are “forward-looking
statements.” These statements are made on the basis of management’s
current views and assumptions. As a result, there can be no assurance
that management’s expectations will necessarily come to pass. These
forward-looking statements generally can be identified by phrases such
as “believes,” “plans,” “expects,” “anticipates,” “foresees,”
“estimated,” “hopes,” “if,” “develops,” “researching,” “research,”
“pilot,” “potential,” “could” or other words or phrases of similar
import. Forward looking statements include descriptions of the Company’s
business strategy, outlook, objectives, plans, intentions and goals. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
those in forward-looking statements. This press release does not
constitute an offer to sell or the solicitation of an offer to buy any
security.
Contacts
Ben Hansel
Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com